Andreas Rummelt Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andreas Rummelt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andreas Rummelt. Andreas Rummelt is Director in ALEXION PHARMACEUTICALS INC ($ALXN).
Andreas Rummelt in ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andreas Rummelt: Director
Holdings: 25,614 shares
Current Value: $3,271,420
Latest Transaction: May 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andreas Rummelt in ALEXION PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 3,468 | 0 | 25,614 | 22.1 K to 25.6 K (+15.66 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 2,726 | 0 | 22,146 | 19.4 K to 22.1 K (+14.04 %) |
May 11 2018 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 2,174 | 0 | 19,420 | 17.2 K to 19.4 K (+12.61 %) |
May 12 2017 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 2,030 | 0 | 17,246 | 15.2 K to 17.2 K (+13.34 %) |
May 13 2016 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | A | 138.86 | 2,294 | 318,545 | 2,294 | |
May 13 2016 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 835 | 0 | 15,216 | 14.4 K to 15.2 K (+5.81 %) |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | A | 155.01 | 2,343 | 363,188 | 2,343 | |
May 08 2015 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 700 | 0 | 13,486 | 12.8 K to 13.5 K (+5.47 %) |
Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 49.43 | 1,393 | 68,856 | 0 | |
Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 24.36 | 3,659 | 89,133 | 0 | |
Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Sell | S | 170.53 | 5,052 | 861,518 | 12,786 | 17.8 K to 12.8 K (-28.32 %) |
Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 49.43 | 1,393 | 68,856 | 17,838 | 16.4 K to 17.8 K (+8.47 %) |
Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 24.36 | 3,659 | 89,133 | 16,445 | 12.8 K to 16.4 K (+28.62 %) |
May 07 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | A | 159.70 | 2,785 | 444,765 | 2,785 | |
Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 895 | 0 | 13,181 | 12.3 K to 13.2 K (+7.28 %) |
May 09 2013 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | A | 96.35 | 3,425 | 329,999 | 3,425 | |
Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 2,471 | 0 | 12,786 | 10.3 K to 12.8 K (+23.96 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Sell | S | 107.00 | 10,000 | 1,070,000 | 10,315 | 20.3 K to 10.3 K (-49.22 %) |
Jun 08 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Sell | S | 91.29 | 10,000 | 912,900 | 20,315 | 30.3 K to 20.3 K (-32.99 %) |
May 09 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | A | 85.75 | 3,237 | 277,573 | 3,237 | |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 24.36 | 3,657 | 89,085 | 3,659 | |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 49.43 | 2,786 | 137,712 | 1,393 | |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Sell | S | 84.96 | 3,657 | 310,699 | 30,315 | 34 K to 30.3 K (-10.76 %) |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 24.36 | 3,657 | 89,085 | 33,972 | 30.3 K to 34 K (+12.06 %) |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Sell | S | 81.27 | 2,786 | 226,418 | 30,315 | 33.1 K to 30.3 K (-8.42 %) |
Feb 23 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 49.43 | 2,786 | 137,712 | 33,101 | 30.3 K to 33.1 K (+9.19 %) |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 0.00 | 3,115 | 0 | 30,315 | 27.2 K to 30.3 K (+11.45 %) |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 49.43 | 1,393 | 68,856 | 4,179 | |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 26.64 | 3,966 | 105,654 | 0 | |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 24.36 | 3,656 | 89,060 | 7,316 | |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Sell | S | 69.01 | 9,015 | 622,125 | 27,200 | 36.2 K to 27.2 K (-24.89 %) |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 49.43 | 1,393 | 68,856 | 36,215 | 34.8 K to 36.2 K (+4.00 %) |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 26.64 | 3,966 | 105,654 | 34,822 | 30.9 K to 34.8 K (+12.85 %) |
Oct 25 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 24.36 | 3,656 | 89,060 | 30,856 | 27.2 K to 30.9 K (+13.44 %) |
May 13 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | A | 98.86 | 2,786 | 275,424 | 2,786 | |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 0.00 | 2,725 | 0 | 13,600 | 10.9 K to 13.6 K (+25.06 %) |
Nov 24 2010 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | S | 53.28 | 1,983 | 105,654 | 1,983 | |
Nov 24 2010 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 53.28 | 1,983 | 105,654 | 10,875 | 8.9 K to 10.9 K (+22.30 %) |
May 13 2010 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | A | 53.28 | 3,966 | 211,308 | 3,966 | |
May 12 2010 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | P | 52.60 | 5,000 | 263,000 | 8,892 | 3.9 K to 8.9 K (+128.47 %) |
Feb 25 2010 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 48.72 | 5,486 | 267,278 | 5,486 | |
Feb 25 2010 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 48.72 | 3,892 | 189,618 | 3,892 | 0 to 3.9 K |
Page: 1